AQR Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

AQR Capital Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-23,551	Closed	-$96K	–	2304
2020 Q4	$96K	Hold	23,551	–	–	﹤0.01%	2154
2020 Q3	$114K	Buy	+23,551	New	+$129K	﹤0.01%	2125
2017 Q3	–	Sell	-155,819	Closed	-$795K	–	2308
2017 Q2	$795K	Sell	155,819 -31,247	-17%	-$176K	﹤0.01%	1747
2017 Q1	$1.29M	Sell	187,066 -26,622	-12%	-$208K	﹤0.01%	1566
2016 Q4	$2M	Buy	213,688 +114,034	+114%	+$1.03M	﹤0.01%	1409
2016 Q3	$975K	Buy	99,654 +39,638	+66%	+$535K	﹤0.01%	1724
2016 Q2	$848K	Sell	60,016 -22,223	-27%	-$347K	﹤0.01%	1673
2016 Q1	$1.15M	Sell	82,239 -12,165	-13%	-$178K	﹤0.01%	1523
2015 Q4	$1.93M	Buy	+94,404	New	+$1.46M	﹤0.01%	1262

Other funds holding AGTC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AQR Capital Management's AGTC Position: Q1 2021 in Review

AQR Capital Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2021, closing a stake of 23,551 shares — an estimated $96K sold.

AQR Capital Management first reported a position in AGTC in Q4 2015 and held it in 9 quarters. The position peaked at $2M in Q4 2016. 82 funds tracked by Wall St. Rank hold AGTC as of Q1 2021.

AQR Capital Management reported no remaining Applied Genetic Technologies Corporation position as of Q1 2021 after selling out during the quarter.
AQR Capital Management sold 23,551 Applied Genetic Technologies Corporation shares in Q1 2021, an estimated $96K.
AQR Capital Management first reported a position in Applied Genetic Technologies Corporation in Q4 2015 and held it in 9 quarters.
AQR Capital Management's Applied Genetic Technologies Corporation position peaked at $2M in Q4 2016.
82 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2021.

Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.